Biomimetic and Bioresponsive Nanotherapies for Inflammatory Vascular Diseases

References

• Benjamin EJ , MuntnerP, AlonsoAet al. Heart disease and stroke statistics – 2019 update: a report from the american heart association. Circulation139(10), e56–e528 (2019).
   PubMed Web of Science ®Google Scholar
• Poellmann MJ , BuJ, HongS. Would antioxidant-loaded nanoparticles present an effective treatment for ischemic stroke?Nanomedicine (Lond.)13(18), 2327–2340 (2018).
   PubMed Web of Science ®Google Scholar
• Cicha I , UnterwegerH, LyerSet al. Nanomedicine for cardiovascular disorders. Nanomedicine (Lond.)14(23), 3007–3012 (2019).
   PubMed Web of Science ®Google Scholar
• Dormont F , VarnaM, CouvreurP. Nanoplumbers: biomaterials to fight cardiovascular diseases. Mater. Today21(2), 122–143 (2018).
   Web of Science ®Google Scholar
• Iafisco M , AlognaA, MiragoliM, CatalucciD. Cardiovascular nanomedicine: the route ahead. Nanomedicine (Lond.)14(18), 2391–2394 (2019).
   PubMed Web of Science ®Google Scholar
• Park JH , DehainiD, ZhouJ, HolayM, FangRH, ZhangL. Biomimetic nanoparticle technology for cardiovascular disease detection and treatment. Nanoscale Horiz.5(1), 25–42 (2020).
   PubMed Web of Science ®Google Scholar
• Duivenvoorden R , TangJ, CormodeDPet al. A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation. Nat. Commun.5, 3065–3065 (2014).
   PubMed Web of Science ®Google Scholar
• Binderup T , DuivenvoordenR, FayFet al. Imaging-assisted nanoimmunotherapy for atherosclerosis in multiple species. Sci. Transl. Med.11(506), eaaw7736 (2019).
   PubMed Web of Science ®Google Scholar
• Rink JS , SunW, MisenerSet al. Nitric oxide-delivering high-density lipoprotein-like nanoparticles as a biomimetic nanotherapy for vascular diseases. ACS Appl. Mater. Interfaces10(8), 6904–6916 (2018).
   PubMed Web of Science ®Google Scholar
• Seijkens TTP , Van TielCM, KustersPJHet al. Targeting CD40-induced TRAF6 signaling in macrophages reduces atherosclerosis. J. Am. Coll. Cardiol.71(5), 527–542 (2018).
   PubMed Web of Science ®Google Scholar
• Jiang C , QiZ, HeWet al. Dynamically enhancing plaque targeting via a positive feedback loop using multifunctional biomimetic nanoparticles for plaque regression. J. Control. Rel.308, 71–85 (2019).
   PubMed Web of Science ®Google Scholar
• Boada C , ZingerA, TsaoCet al. Rapamycin-loaded biomimetic nanoparticles reverse vascular inflammation. Circ. Res.126(1), 25–37 (2020).
   PubMed Web of Science ®Google Scholar
• Wei X , YingM, DehainiDet al. Nanoparticle functionalization with platelet membrane enables multifactored biological targeting and detection of atherosclerosis. ACS Nano12(1), 109–116 (2018).
   PubMed Web of Science ®Google Scholar
• Wang Y , ZhangK, QinXet al. Biomimetic nanotherapies: red blood cell based core-shell structured nanocomplexes for atherosclerosis management. Adv. Sci.6(12), 1900172 (2019).
   Web of Science ®Google Scholar
• Wu G , WeiW, ZhangJet al. A self-driven bioinspired nanovehicle by leukocyte membrane-hitchhiking for early detection and treatment of atherosclerosis. Biomaterials250, 119963 (2020).
   PubMed Web of Science ®Google Scholar
• Zhang X , XuX, ChenYet al. Bioinspired yeast microcapsules loaded with self-assembled nanotherapies for targeted treatment of cardiovascular disease. Mater. Today20(6), 301–313 (2017).
   Web of Science ®Google Scholar
• Hu CMJ , FangRH, WangKCet al. Nanoparticle biointerfacing by platelet membrane cloaking. Nature526(7571), 118–121 (2015).
   PubMed Web of Science ®Google Scholar
• Lv W , XuJ, WangX, LiX, XuQ, XinH. Bioengineered boronic ester modified dextran polymer nanoparticles as reactive oxygen species responsive nanocarrier for ischemic stroke treatment. ACS Nano12(6), 5417–5426 (2018).
   PubMed Web of Science ®Google Scholar
• Dong X , GaoJ, ZhangCY, HayworthC, FrankM, WangZ. Neutrophil membrane-derived nanovesicles alleviate inflammation to protect mouse brain injury from ischemic stroke. ACS Nano13(2), 1272–1283 (2019).
   PubMed Web of Science ®Google Scholar
• Cheng J , ZhangR, LiCet al. A targeting nanotherapy for abdominal aortic aneurysms. J. Am. Coll. Cardiol.72(21), 2591–2605 (2018).
   PubMed Web of Science ®Google Scholar
• Feng S , HuY, PengSet al. Nanoparticles responsive to the inflammatory microenvironment for targeted treatment of arterial restenosis. Biomaterials105, 167–184 (2016).
   PubMed Web of Science ®Google Scholar
• Dou Y , ChenY, ZhangXet al. Non-proinflammatory and responsive nanoplatforms for targeted treatment of atherosclerosis. Biomaterials143, 93–108 (2017).
   PubMed Web of Science ®Google Scholar
• Zhang R , LiuR, LiuCet al. A pH/ROS dual-responsive and targeting nanotherapy for vascular inflammatory diseases. Biomaterials230, 119605 (2020).
   PubMed Web of Science ®Google Scholar
• Wang Y , LiL, ZhaoWet al. Targeted therapy of atherosclerosis by a broad-spectrum reactive oxygen species scavenging nanoparticle with intrinsic anti-inflammatory activity. ACS Nano12(9), 8943–8960 (2018).
   PubMed Web of Science ®Google Scholar
• Guo J , LiD, TaoHet al. Cyclodextrin-derived intrinsically bioactive nanoparticles for treatment of acute and chronic inflammatory diseases. Adv. Mater.31, 1904607 (2019).
   Web of Science ®Google Scholar
• Cho BR , RyuDR, LeeKSet al. p-Hydroxybenzyl alcohol-containing biodegradable nanoparticle improves functional blood flow through angiogenesis in a mouse model of hindlimb ischemia. Biomaterials53, 679–687 (2015).
   PubMed Web of Science ®Google Scholar
• Lu Y , LiC, ChenQet al. Microthrombus-targeting micelles for neurovascular remodeling and enhanced microcirculatory perfusion in acute ischemic stroke. Adv. Mater.31(21), 1808361 (2019).
   Web of Science ®Google Scholar
• Mei T , KimA, VongLBet al. Encapsulation of tissue plasminogen activator in pH-sensitive self-assembled antioxidant nanoparticles for ischemic stroke treatment-synergistic effect of thrombolysis and antioxidant. Biomaterials215, 119209 (2019).
   PubMed Web of Science ®Google Scholar
• Kang C , GwonS, SongCet al. Fibrin-targeted and H2O2-responsive nanoparticles as a theranostics for thrombosed vessels. ACS Nano11(6), 6194–6203 (2017).
   PubMed Web of Science ®Google Scholar
• Guo X , DengG, LiuJet al. Thrombin-responsive, brain-targeting nanoparticles for improved stroke therapy. ACS Nano12(8), 8723–8732 (2018).
   PubMed Web of Science ®Google Scholar